Background
Methods
Sampling
Survey instrument
Pre-implementation survey | Post-implementation survey | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Survey Questions | n | UC n (%) | CDS n (%) | CDS + SDMT n (%) | p | n | UC n (%) | CDS n (%) | CDS + SDMT n (%) | p |
Age Range (years) | 164 | 0.129 | 165 | 0.449 | ||||||
≤ 34 | 15 (25.0) | 11 (19.0) | 8 (17.4) | 14 (22.2) | 9 (18.0) | 16 (30.8) | ||||
35–44 | 12 (20.0) | 19 (32.8) | 7 (15.2) | 17 (27.0) | 18 (36.0) | 9 (17.3) | ||||
45–54 | 17 (28.3) | 10 (17.2) | 8 (17.4) | 14 (22.2) | 11 (22.0) | 15 (28.9) | ||||
55–64 | 10 (16.7) | 15 (25.9) | 17 (37.0) | 13 (20.6) | 11 (22.0) | 9 (17.3) | ||||
≥ 65 | 6 (10.0) | 3 (5.2) | 6 (13.0) | 5 (7.9) | 1 (2.0) | 3 (5.8) | ||||
Pre-post within arm pa | 0.809b | 0.892 | 0.089 | |||||||
Current Role | 165 | 0.022 | 166 | 0.009 | ||||||
Nurse Practitioner | 17 (28.3) | 26 (44.8) | 9 (19.2) | 15 (23.8) | 26 (51.0) | 13 (25.0) | ||||
Physician Assistant | 6 (10.0) | 1 (1.7) | 9 (19.2) | 11 (17.5) | 2 (3.9) | 11 (21.2) | ||||
Family Practice physician | 27 (45.0) | 26 (44.8) | 22 (46.8) | 30 (47.6) | 18 (35.3) | 23 (44.2) | ||||
Internal medicine physician | 9 (15.0) | 5 (8.6) | 6 (12.8) | 7 (11.1) | 3 (5.9) | 5 (9.6) | ||||
Other | 1 (1.7) | 0 (0.0) | 1 (2.1) | 0 (0.0) | 2 (3.9) | 0 (0.0) | ||||
Pre-post within arm pa | 0.609 | 0.503 | 0.853 | |||||||
Years in practice | 165 | 0.020b | 166 | 0.540b | ||||||
≤ 5 | 24 (40.0) | 19 (32.8) | 10 (21.3) | 21 (33.3) | 16 (31.4) | 23 (44.2) | ||||
6–10 | 5 (8.3) | 14 (24.1) | 5 (10.6) | 12 (19.1) | 11 (21.6) | 6 (11.5) | ||||
≥ 11 | 31 (51.7) | 25 (43.1) | 32 (68.1) | 30 (47.6) | 24 (47.1) | 23 (44.2) | ||||
Pre-post within arm pa | 0.220b | 0.910b | 0.040 | |||||||
Days/week seeing patients | 165 | 0.015 | 166 | 0.083 | ||||||
0–2 | 3 (5.0) | 4 (6.9) | 11 (23.4) | 0 (0.0) | 3 (5.9) | 4 (7.7) | ||||
3 | 13 (21.7) | 9 (15.5) | 4 (8.5) | 11 (17.5) | 11 (21.6) | 6 (11.5) | ||||
4 | 20 (33.3) | 27 (46.6) | 22 (46.8) | 22 (34.9) | 17 (33.3) | 26 (50.0) | ||||
5 | 24 (40.0) | 18 (31.0) | 10 (21.3) | 30 (47.6) | 20 (39.2) | 16 (30.8) | ||||
Pre-post within arm pa | 0.329 | 0.521 | 0.169 | |||||||
Sex | 165 | 0.814b | 166 | 0.925b | ||||||
Female | 39 (65.0) | 35 (60.3) | 28 (59.6) | 40 (64.5) | 34 (68.0) | 34 (65.4) | ||||
Male | 21 (35.0) | 23 (39.7) | 19 (40.4) | 22 (35.5) | 16 (32.0) | 18 (34.6) | ||||
Pre-post within arm pa | 0.955b | 0.409b | 0.551b |
Pre-implementation survey | Post-implementation survey | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Survey Questions | n | UC n (%) | CDS n (%) | CDS + SDMT n (%) | p | n | UC n (%) | CDS n (%) | CDS + SDMT n (%) | p |
How well prepared do you feel to prioritize cancer risk factors and screening and discuss them with your patients? | ||||||||||
Not Prepared | 164 | 1 (1.7) | 1 (1.7) | 2 (4.3) | 0.891 | 172 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.056 |
Somewhat Prepared | 22 (37.3) | 19 (32.8) | 16 (34.0) | 14 (21.2) | 22 (41.5) | 17 (32.1) | ||||
Very Prepared | 36 (61.0) | 38 (65.5) | 29 (61.7) | 52 (78.8) | 31 (58.5) | 36 (67.9) | ||||
Pre-post within arm pa | 0.038 | 0.431 | 0.392 | |||||||
In relation to other health issues, what level of priority do your patients give cancer screening? | ||||||||||
Low Priority | 165 | 4 (6.7) | 2 (3.5) | 0 (0.0) | 0.361 | 170 | 2 (3.1) | 4 (7.7) | 1 (1.9) | 0.669 |
Medium Priority | 28 (46.7) | 22 (37.9) | 21 (44.7) | 34 (52.3) | 24 (46.2) | 26 (49.1) | ||||
High Priority | 28 (46.7) | 34 (58.6) | 26 (55.3) | 29 (44.6) | 24 (46.2) | 26 (49.1) | ||||
Pre-post within arm pa | 0.598 | 0.376 | 0.760 | |||||||
How comfortable are you advising your patients on breast cancer screening options? | ||||||||||
Very uncomfortable | 155 | 0 (0.0) | 0 (0.0) | 1 (2.3) | 0.754 | 171 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.038 |
Somewhat uncomfortable | 1 (1.8) | 0 (0.0) | 1 (2.3) | 1 (1.5) | 0 (0.0) | 4 (7.6) | ||||
Somewhat comfortable | 13 (23.2) | 16 (28.6) | 10 (23.3) | 24 (36.4) | 27 (51.9) | 27 (50.9) | ||||
Very comfortable | 42 (75.0) | 40 (71.4) | 31 (72.1) | 41 (62.1) | 25 (48.1) | 22 (41.5) | ||||
Pre-post within arm pa | 0.240 | 0.013 | 0.004 | |||||||
How comfortable are you advising patients about selecting a particular method of colorectal cancer screening? | ||||||||||
Very uncomfortable | 153 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.089 | 167 | 0 (0.0) | 0 (0.0) | 1 (1.9) | 0.434 |
Somewhat uncomfortable | 0 (0.0) | 0 (0.0) | 1 (2.4) | 1 (1.6) | 1 (1.9) | 1 (1.9) | ||||
Somewhat comfortable | 14 (25.5) | 8 (14.3) | 4 (9.5) | 8 (12.7) | 12 (23.1) | 12 (23.1) | ||||
Very comfortable | 41 (74.6) | 48 (85.7) | 37 (88.1) | 54 (85.7) | 39 (75.0) | 38 (73.1) | ||||
Pre-post within arm pa | 0.098 | 0.268 | 0.169 | |||||||
How comfortable are you advising patients about selecting a particular method of lung cancer screening? | ||||||||||
Very uncomfortable | 145 | 0 (0.0) | 0 (0.0) | 1 (2.6) | 0.783 | 166 | 0 (0.0) | 1 (2.0) | 0 (0.0) | 0.213 |
Somewhat uncomfortable | 4 (7.7) | 4 (7.4) | 5 (12.8) | 3 (4.8) | 7 (13.7) | 5 (9.6) | ||||
Somewhat comfortable | 21 (40.4) | 24 (44.4) | 16 (41.0) | 22 (34.9) | 22 (43.1) | 17 (32.7) | ||||
Very comfortable | 27 (51.9) | 26 (48.2) | 17 (43.6) | 38 (60.3) | 21 (41.2) | 30 (57.7) | ||||
Pre-post within arm pa | 0.625 | 0.518 | 0.433 | |||||||
How often did you recommend colorectal cancer screening tests other than colonoscopy to your asymptomatic, average-risk patients during the past 12 months? | ||||||||||
Never | 153 | 2 (3.6) | 1 (1.8) | 1 (2.4) | 0.806 | 168 | 0 (0.0) | 3 (5.8) | 2 (3.9) | 0.349 |
Sometimes | 23 (41.8) | 28 (50.0) | 19 (45.2) | 21 (32.8) | 20 (38.5) | 18 (34.6) | ||||
Usually | 12 (21.8) | 14 (25.0) | 7 (16.7) | 17 (26.6) | 16 (30.8) | 17 (32.7) | ||||
Always | 18 (32.7) | 13 (23.2) | 15 (35.7) | 26 (40.6) | 13 (25.0) | 15 (28.9) | ||||
Pre-post within arm pa | 0.338 | 0.521 | 0.330 | |||||||
At preventive care visits, how often do you use a cancer risk calculation for any of the following? | ||||||||||
Breast cancer (e.g., BCRAT) | ||||||||||
Never | 154 | 44 (80.0) | 43 (76.8) | 37 (86.1) | 0.225 | 171 | 44 (67.7) | 39 (73.6) | 34 (65.4) | 0.855 |
Sometimes | 9 (16.4) | 10 (17.9) | 2 (4.7) | 15 (22.7) | 9 (17.0) | 14 (26.9) | ||||
Usually | 2 (3.6) | 1 (1.8) | 2 (4.7) | 5 (7.6) | 4 (7.6) | 2 (3.9) | ||||
Always | 0 (0.0) | 2 (3.6) | 2 (4.7) | 2 (3.0) | 1 (1.9) | 2 (3.9) | ||||
Pre-post within arm pa | 0.328 | 0.569 | 0.017 | |||||||
Colorectal cancer | ||||||||||
Never | 153 | 48 (87.3) | 46 (82.1) | 36 (85.7) | 0.745 | 169 | 56 (84.9) | 42 (82.4) | 35 (67.3) | 0.161 |
Sometimes | 5 (9.1) | 7 (12.5) | 3 (7.1) | 6 (9.1) | 4 (7.8) | 12 (23.1) | ||||
Usually | 2 (3.6) | 1 (1.8) | 1 (2.4) | 2 (3.0) | 4 (7.8) | 4 (7.7) | ||||
Always | 0 (0.0) | 2 (3.6) | 2 (4.8) | 2 (3.0) | 1 (2.0) | 1 (1.9) | ||||
Pre-post within arm pa | 0.778 | 0.440 | 0.080 | |||||||
Lung cancer (e.g., CDC/AHRQ) | ||||||||||
Never | 154 | 42 (76.4) | 43 (76.8) | 35 (81.4) | 0.936 | 164 | 46 (74.2) | 35 (68.6) | 25 (49.0) | 0.184 |
Sometimes | 7 (12.7) | 7 (12.5) | 5 (11.6) | 9 (14.5) | 9 (17.7) | 15 (29.4) | ||||
Usually | 5 (9.1) | 3 (5.4) | 2 (4.7) | 5 (8.1) | 4 (7.8) | 6 (11.8) | ||||
Always | 1 (1.8) | 3 (5.4) | 1 (2.3) | 2 (3.2) | 3 (5.9) | 5 (9.8) | ||||
Pre-post within arm pa | 0.979 | 0.783 | 0.012 |
Pre-Implementation Survey | Post-Implementation Survey | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Survey Questions | n | UC n (%) | CDS n (%) | CDS + SDMT n (%) | p | n | UC n (%) | CDS n (%) | CDS + SDMT n (%) | p |
Consider the last patient you saw regarding colorectal cancer screening. For each of the following six statements related to the decision-making in this consultation, please select the response that best describes your actions with this patient. | ||||||||||
I told my patient that there are different screening options (e.g. FIT, Colonoscopy) | ||||||||||
Agree | 152 | 49 (89.1) | 49 (87.5) | 39 (95.1) | 0.838 | 168 | 56 (87.5) | 45 (86.5) | 47 (90.4) | 0.409 |
Neither | 1 (1.8) | 1 (1.8) | 0 (0.0) | 0 (0) | 1 (1.9) | 2 (3.9) | ||||
Disagree | 5 (9.1) | 6 (10.7) | 2 (4.9) | 8 (12.5) | 6 (11.5) | 3 (5.8) | ||||
Pre-post within arm pa | 0.559 | 1.000 | 0.691 | |||||||
I explained the advantage and disadvantages of the screening options to my patient | ||||||||||
Agree | 152 | 49 (89.1) | 49 (87.5) | 40 (97.6) | 0.489 | 167 | 56 (87.5) | 45 (86.5) | 46 (90.2) | 0.411 |
Neither | 1 (1.8) | 2 (3.6) | 0 (0.0) | 0 (0) | 1 (1.9) | 2 (3.9) | ||||
Disagree | 5 (9.1) | 5 (8.9) | 1 (2.4) | 8 (12.5) | 6 (11.5) | 3 (5.9) | ||||
Pre-post within arm pa | 0.559 | 0.905 | 0.448 | |||||||
I helped my patient understand all the information | ||||||||||
Agree | 150 | 49 (90.7) | 47 (85.5) | 40 (97.6) | 0.442 | 166 | 54 (87.1) | 45 (86.5) | 46 (88.5) | 0.601 |
Neither | 2 (3.7) | 3 (5.5) | 0 (0.0) | 1 (1.6) | 1 (1.9) | 3 (5.8) | ||||
Disagree | 3 (5.6) | 5 (9.1) | 1 (2.4) | 7 (11.3) | 6 (11.5) | 3 (5.8) | ||||
Pre-post within arm pa | 0.440 | 0.688 | 0.284 | |||||||
I asked my patient which screening option he/she prefers | ||||||||||
Agree | 152 | 47 (85.5) | 50 (89.3) | 38 (92.7) | 0.837 | 168 | 53 (82.8) | 43 (82.7) | 47 (90.4) | 0.152 |
Neither | 2 (3.6) | 1 (1.8) | 1 (2.4) | 0 (0) | 2 (3.9) | 2 (3.9) | ||||
Disagree | 6 (10.9) | 5 (8.9) | 2 (4.9) | 11 (17.2) | 7 (13.5) | 3 (5.8) | ||||
Pre-post within arm pa | 0.206 | 0.583 | 1.000 | |||||||
My patient and I selected a screening option together | ||||||||||
Agree | 150 | 43 (78.2) | 49 (87.5) | 38 (97.4) | 0.054 | 168 | 53 (82.8) | 45 (86.5) | 46 (88.5) | 0.302 |
Neither | 7 (12.7) | 2 (3.6) | 0 (0.0) | 0 (0) | 1 (1.9) | 2 (3.9) | ||||
Disagree | 5 (9.1) | 5 (8.9) | 1 (2.6) | 11 (17.2) | 6 (11.5) | 4 (7.7) | ||||
Pre-post within arm pa | 0.005 | 0.905 | 0.383 | |||||||
My patient and I reached an agreement on how to proceed | ||||||||||
Agree | 150 | 46 (83.6) | 46 (85.2) | 38 (92.7) | 0.522 | 167 | 54 (85.7) | 45 (86.5) | 47 (90.4) | 0.324 |
Neither | 5 (9.1) | 2 (3.7) | 1 (2.4) | 0 (0) | 1 (1.9) | 2 (3.8) | ||||
Disagree | 4 (7.3) | 6 (11.1) | 2 (4.9) | 9 (14.3) | 6 (11.5) | 3 (5.8) | ||||
Pre-post within arm pa | 0.025 | 1.000 | 1.000 | |||||||
Consider the last patient you saw who was a possible candidate for lung cancer screening. For each of the following two statements related to the decision-making in this consultation, please select the response that best describes your actions with this patient. | ||||||||||
I helped my patient understand all the risks and benefits and details about screening | ||||||||||
Agree | 146 | 37 (69.8) | 35 (64.8) | 28 (71.8) | 0.665 | 165 | 53 (84.1) | 40 (78.4) | 43 (84.3) | 0.030 |
Neither | 6 (11.3) | 11 (20.4) | 4 (10.3) | 2 (3.2) | 9 (17.7) | 2 (3.9) | ||||
Disagree | 10 (18.9) | 8 (14.8) | 7 (18.0) | 8 (12.7) | 2 (3.9) | 6 (11.8) | ||||
Pre-post within arm pa | 0.122 | 0.136 | 0.305 | |||||||
My patient and I reached an agreement on how to proceed | ||||||||||
Agree | 142 | 37 (69.8) | 34 (65.4) | 26 (70.3) | 0.957 | 159 | 50 (84.8) | 39 (79.6) | 44 (86.3) | 0.002 |
Neither | 9 (17.0) | 10 (19.2) | 5 (13.5) | 1 (1.7) | 9 (18.4) | 1 (2.0) | ||||
Disagree | 7 (13.2) | 8 (15.4) | 6 (16.2) | 8 (13.6) | 1 (2.0) | 6 (11.8) | ||||
Pre-post within arm pa | 0.015 | 0.060 | 0.076 |
Pre-Implementation Survey | Post-Implementation Survey | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Survey Questions | n | UC n (%) | CDS n (%) | CDS + SDMT n (%) | p | n | UC n (%) | CDS n (%) | CDS + SDMT n (%) | p |
Select “yes” or “no” for the following questions on the EMR your clinic uses for screening of breast, cervical, colorectal, or lung cancers or HPV vaccination. | ||||||||||
The EMR alerts me that this action is due. | ||||||||||
Breast Cancer Screening | 156 | 56 (96.6) | 50 (90.9) | 40 (93.0) | 0.506a | 171 | 66 (100) | 50 (96.2) | 51 (96.2) | 0.247a |
Pre-post within arm pb | 0.217a | 0.439a | 0.654a | |||||||
Cervical Cancer Screening | 155 | 20 (35.1) | 18 (32.7) | 12 (27.9) | 0.745 | 172 | 29 (43.9) | 29 (54.7) | 23 (43.4) | 0.409 |
Pre-post within arm pb | 0.317 | 0.021 | 0.117 | |||||||
Colorectal Screening | 153 | 54 (94.7) | 49 (90.7) | 36 (85.7) | 0.310a | 172 | 64 (97.0) | 48 (90.6) | 49 (92.5) | 0.380a |
Pre-post within arm pb | 0.662a | 0.975 | 0.329a | |||||||
Lung Screening | 153 | 41 (73.2) | 35 (63.6) | 21 (50.0) | 0.062 | 169 | 56 (86.2) | 43 (84.3) | 40 (75.5) | 0.287 |
Pre-post within arm pb | 0.075 | 0.016 | 0.010 | |||||||
HPV Vaccination | 153 | 39 (70.9) | 44 (80.0) | 30 (69.8) | 0.429 | 168 | 41 (65.1) | 37 (71.2) | 37 (69.8) | 0.758 |
Pre-post within arm pb | 0.499 | 0.286 | 0.996 | |||||||
The EMR makes it easy for me to order the needed service. | ||||||||||
Breast Cancer Screening | 154 | 49 (87.5) | 44 (80.0) | 37 (86.1) | 0.520 | 171 | 58 (87.9) | 42 (80.8) | 46 (86.8) | 0.522 |
Pre-post within arm pb | 0.949 | 0.920 | 0.915 | |||||||
Cervical Cancer Screening | 153 | 30 (53.6) | 34 (61.8) | 28 (66.7) | 0.403 | 170 | 44 (67.7) | 34 (65.4) | 36 (67.9) | 0.953 |
Pre-post within arm pb | 0.112 | 0.702 | 0.897 | |||||||
Colorectal Screening | 153 | 51 (91.1) | 40 (74.1) | 37 (86.1) | 0.048 | 172 | 63 (95.5) | 45 (84.9) | 47 (88.7) | 0.130a |
Pre-post within arm pb | 0.468a | 0.166 | 0.698 | |||||||
Lung Screening | 149 | 42 (75.0) | 30 (56.6) | 26 (65.0) | 0.128 | 172 | 57 (86.4) | 40 (75.5) | 41 (77.4) | 0.273 |
Pre-post within arm pb | 0.110 | 0.043 | 0.189 | |||||||
HPV Vaccination | 148 | 40 (74.1) | 43 (82.7) | 30 (71.4) | 0.391 | 167 | 44 (69.8) | 35 (68.6) | 36 (67.9) | 0.975 |
Pre-post within arm pb | 0.612 | 0.960 | 0.713 | |||||||
The EMR enables me to print out materials that help patients identify their preferred screening method. | ||||||||||
Breast Cancer Screening | 151 | 18 (32.7) | 20 (37.0) | 11 (26.2) | 0.530 | 165 | 17 (26.2) | 25 (50.0) | 20 (40.0) | 0.030 |
Pre-post within arm pb | 0.430 | 0.183 | 0.163 | |||||||
Cervical Cancer Screening | 149 | 16 (29.1) | 17 (32.1) | 9 (22.0) | 0.547 | 165 | 16 (24.6) | 25 (50.0) | 16 (32.0) | 0.016 |
Pre-post within arm pb | 0.581 | 0.064 | 0.285 | |||||||
Colorectal Screening | 148 | 19 (34.6) | 22 (43.1) | 14 (33.3) | 0.548 | 165 | 18 (27.7) | 26 (52.0) | 20 (40.0) | 0.029 |
Pre-post within arm pb | 0.418 | 0.373 | 0.509 | |||||||
Lung Screening | 148 | 18 (33.3) | 18 (34.0) | 11 (26.8) | 0.726 | 163 | 23 (35.9) | 26 (52.0) | 20 (40.8) | 0.220 |
Pre-post within arm pb | 0.767 | 0.064 | 0.164 | |||||||
HPV Vaccination | 145 | 20 (38.5) | 21 (40.4) | 10 (24.4) | 0.228 | 160 | 17 (26.6) | 23 (48.9) | 20 (40.8) | 0.047 |
Pre-post within arm pb | 0.172 | 0.393 | 0.100 | |||||||
The EMR makes it easy to calculate cancer risks for individual patients. | ||||||||||
Breast Cancer Screening | 152 | 4 (7.1) | 5 (9.1) | 3 (7.3) | 0.932a | 170 | 8 (12.1) | 11 (21.6) | 12 (22.6) | 0.256 |
Pre-post within arm pb | 0.544a | 0.073 | 0.051a | |||||||
Cervical Cancer Screening | 153 | 5 (8.9) | 4 (7.3) | 2 (4.8) | 0.861a | 170 | 5 (7.7) | 9 (17.3) | 9 (17.0) | 0.216 |
Pre-post within arm pb | 0.806 | 0.144a | 0.105a | |||||||
Colorectal Screening | 153 | 6 (10.7) | 6 (10.9) | 4 (9.5) | 1.000a | 168 | 5 (7.7) | 8 (15.4) | 13 (25.5) | 0.031 |
Pre-post within arm pb | 0.564 | 0.493 | 0.061a | |||||||
Lung Screening | 151 | 14 (25.5) | 9 (16.4) | 6 (14.6) | 0.329a | 169 | 15 (22.7) | 13 (25.5) | 20 (38.5) | 0.146 |
Pre-post within arm pb | 0.726 | 0.247 | 0.011 | |||||||
HPV Vaccination | 152 | 10 (18.2) | 6 (10.9) | 3 (7.1) | 0.262a | 166 | 6 (9.2) | 7 (14.3) | 12 (23.1) | 0.113 |
Pre-post within arm pb | 0.151 | 0.603 | 0.048a |
Survey Questions | n | CDS n (%) | CDS + SDMT n (%) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Please indicate the extent to which you agree or disagree with the following statements. The Wizard... | Agree | Neither | Disagree | Agree | Neither | Disagree | p | |||
Helps get more patients screened for cancer | 101 | 21 (41.2) | 15 (29.4) | 15 (29.4) | 29 (58.0) | 13 (26.0) | 8 (16.0) | 0.170 | ||
Saves me time talking to patients | 101 | 6 (11.8) | 18 (35.3) | 27 (52.9) | 11 (22.0) | 20 (40.0) | 19 (38.0) | 0.228 | ||
Increases the appointment length | 100 | 25 (50.0) | 20 (40.0) | 5 (10.0) | 24 (48.0) | 20 (40.0) | 6 (12.0) | 0.946 | ||
Is a useful tool for shared decision-making | 99 | 24 (50.0) | 17 (35.4) | 7 (14.6) | 31 (60.8) | 15 (29.4) | 5 (9.8) | 0.533 | ||
Influences my treatment recommendations | 101 | 14 (28.0) | 20 (40.0) | 16 (32.0) | 28 (54.9) | 14 (27.5) | 9 (17.7) | 0.022 | ||
Influences my patients’ decisions | 102 | 13 (25.5) | 23 (45.1) | 15 (29.4) | 23 (45.1) | 20 (39.2) | 8 (15.7) | 0.077 | ||
Helps me place orders | 101 | 11 (22.0) | 18 (36.0) | 21 (42.0) | 13 (25.5) | 18 (35.3) | 20 (39.2) | 0.913 | ||
Provides accurate information | 100 | 23 (46.0) | 21 (42.0) | 6 (12.0) | 30 (60.0) | 15 (30.0) | 5 (10.0) | 0.365 | ||
How often do you … .. | Always | Usually | Sometimes | Never | Always | Usually | Sometimes | Never | p | |
Use the Wizard paper printoutsa | 102 | 3 (5.9) | 6 (11.8) | 23 (45.1) | 19 (37.3) | 3 (5.9) | 7 (13.7) | 24 (47.1) | 17 (33.3) | 0.975 |
Use the Wizard on-screen (n = 51/51)a | 102 | 1 (2.0) | 5 (9.8) | 16 (31.4) | 29 (56.9) | 1 (2.0) | 9 (17.7) | 20 (39.2) | 21 (41.2) | 0.382 |
Use the tools within the Wizard’s Decision Aid tab (n = 51/48)a | 99 | 0 (0) | 3 (6.3) | 15 (31.3) | 30 (62.5) | 1 (2.0) | 5 (9.8) | 22 (43.1) | 23 (45.1) | 0.274 |
Yes definitely | Yes somewhat | No | Yes definitely | Yes somewhat | No | p | ||||
Do your patients like the Wizard’s information regarding cancer screening and prevention?a | 92 | 0 (0) | 32 (72.7) | 12 (27.3) | 12 (25.0) | 23 (47.9) | 13 (27.1) | < 0.001 | ||
Is there value in patients taking the Wizard information home with them? | 95 | 5 (10.9) | 32 (69.6) | 9 (19.6) | 17 (34.7) | 20 (40.8) | 12 (24.5) | 0.008 | ||
Would you recommend the Wizard to colleagues?a | 96 | 2 (4.4) | 28 (60.9) | 16 (34.8) | 11 (22.0) | 28 (56.0) | 11 (22.0) | 0.030 | ||
Does the Wizard alert you when a patient is overdue for a cancer screening you were NOT aware of? | 97 | 8 (17.0) | 19 (40.4) | 20 (42.6) | 11 (22.0) | 23 (46.0) | 16 (32.0) | 0.547 | ||
Very satisfied | Somewhat satisfied | Not at all satisfied | Very satisfied | Somewhat satisfied | Not at all satisfied | p | ||||
Regarding cancer screening and prevention, how satisfied are you with the Wizard?a | 96 | 4 (8.5) | 31 (66.0) | 12 (25.5) | 13 (26.5) | 28 (57.1) | 8 (16.3) | 0.062 |